Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000904454-18-000424

Options or other derivatives

  • Director acquired 18,324 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TREU JESSE I Director 2018-06-07 Grant or award · Stock Option (right to buy) +15,526 15,526 D
TREU JESSE I Director 2018-06-07 Grant or award · Stock Option (right to buy) +1,354 1,354 D
TREU JESSE I Director 2018-06-07 Grant or award · Stock Option (right to buy) +1,444 1,444 D
Loading xslF345X03/edgar.xml…